Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Current Treatment Options in Infectious Diseases|December 8, 2018
Building a Hepatitis C Clinical Program: Strategies to Optimize OutcomesAutumn Zuckerman, Alicia Carver, Cody A ChastainCurrent Treatment Options in Infectious Diseases|December 16, 2017
Retreatment Options Following HCV Direct Acting Antiviral FailureAutumn Zuckerman, Cody A Chastain, Susanna NaggieCurrent HIV/AIDS Reports|November 26, 2013
Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014Cody A Chastain, Susanna NaggieClinical Case Reports|August 21, 2019
Colonic and perianal ulceration exhibiting vacuolar interface dermatitis in the setting of HIVJoseph Tadros, Cody A Chastain, Eric TkaczykJournal of Acquired Immune Deficiency Syndromes (1999)|December 5, 2024
Increasing the Accessibility and Relevance of Implementation Science for Front-Line ImplementersSarit A Golub, Carly Wolfer, Cody A ChastainPharmacotherapy|April 24, 2014
Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonideWhitney Jones, Cody A Chastain, Patty W WrightClinics in Podiatric Medicine and Surgery|May 14, 2019
A Clinical Review of Diabetic Foot InfectionsCody A Chastain, Nathan Klopfenstein, Carlos H Serezani, et al.Journal of Pharmacy Practice|January 2, 2023
Assessing Pharmacist Interventions at an Outpatient Renal Transplant Clinic Under a Collaborative Pharmacy Practice AgreementRachel Chelewski, Keren Rodriguez, Megan Peter, et al.Open Forum Infectious Diseases|January 7, 2021
Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral TherapyAlicia B Carver, Autumn D Zuckerman, Joshua DeClercq, et al.Plos One|June 19, 2018
Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral eraAutumn Zuckerman, Andrew Douglas, Sam Nwosu, et al.Pageof 5